
    
      The study was a parallel control design trial for 2 weeks. Patients with schizophrenia were
      treated with 10-Hz rTMS on left motor cortex (added to the ongoing treatment). Clinical
      symptoms and MEP were assessment before and after rTMS treatment.
    
  